S
CLB icon

Sachetta’s Core Laboratories CLB Stock Holding History

Sachetta’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$373 Hold
32
– – ﹤0.01% 954
2026
Q1 		$538 Hold
32
– – ﹤0.01% 1026
2025
Q4 		$513 Hold
32
– – ﹤0.01% 983
2025
Q3 		$396 Hold
32
– – ﹤0.01% 1033
2025
Q2 		$369 Hold
32
– – ﹤0.01% 1056
2025
Q1 		$480 Hold
32
– – ﹤0.01% 1046
2024
Q4 		$554 Hold
32
– – ﹤0.01% 1084
2024
Q3 		$593 Hold
32
– – ﹤0.01% 1122
2024
Q2 		$784 Hold
32
– – ﹤0.01% 1100
2024
Q1 		$566 Hold
32
– – ﹤0.01% 1050
2023
Q4 		$566 Buy
+32
New +$645 ﹤0.01% 1050

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sachetta's CLB Position: Q2 2026 in Review

Sachetta held its Core Laboratories (CLB) position steady in Q2 2026 at 32 shares worth $373. The position accounts for ﹤0.01% of the portfolio, ranked #954.

Sachetta first reported a position in CLB in Q4 2023 and has held it in 11 quarters since. The position peaked at $784 in Q2 2024. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Sachetta held 32 shares of Core Laboratories worth $373 as of Q2 2026.
  • Sachetta left its Core Laboratories share count unchanged in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Sachetta's portfolio in Q2 2026, its #954 holding.
  • Sachetta first reported a position in Core Laboratories in Q4 2023 and has held it in 11 quarters since.
  • Sachetta's Core Laboratories position peaked at $784 in Q2 2024.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Sachetta's 13F filing for Q2 2026, filed 15 Jul 2026.